Prior Stephen David

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 29% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Prior Stephen David's trades of AN2 Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
104.84
Quantity 52,469 -9.5%
Value US$3,335,662
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-07 2026-01-06
S Sale
36,315 +47.5%
470.54
US$2,086,550 		36,315 +47.5% 470.54 US$2,086,550
2026-01-07 2026-01-05
S Sale
89,584 -7.9%
366.06
US$2,982,141 		89,584 -7.9% 366.06 US$2,982,141
2025-11-06 2025-11-04
PlS Planned sale
52,469 -9.5%
104.84
US$3,335,662 		52,469 -9.5% 104.84 US$3,335,662
2025-01-07 2025-01-03
S Sale
2,029 -5.7%
1.34
US$2,721 		2,029 -5.7% 1.34 US$2,721